16:40:28 EDT Fri 24 May 2024
Enter Symbol
or Name
USA
CA



MCI Onehealth Technologies Inc
Symbol DRDR
Shares Issued 50,075,202
Close 2022-05-09 C$ 1.23
Market Cap C$ 61,592,498
Recent Sedar Documents

MCI Onehealth to release Q1 results, host call May 16

2022-05-09 17:14 ET - News Release

Dr. Alexander Dobranowski reports

MCI ONEHEALTH ANNOUNCES DATE OF ITS FIRST QUARTER 2022 EARNINGS CALL

MCI Onehealth Technologies Inc. will release its financial results for the three months ended March 31, 2022, on May 16, 2022, after the close of market.

MCI Onehealth will host a conference call and webcast on the same day at 5:30 p.m. ET to discuss the financial results and progress toward its key strategic initiatives. The call will be hosted by Dr. Alexander Dobranowski, chief executive officer, and Scott Nirenberski, chief financial officer. Please dial in 10 minutes prior to the start of the call.

Conference call details

Date:  May 16, 2022

Time:  5:30 p.m. ET

Duration:  60 minutes

Dial-in Canada/United States:  833-540-1153 (toll-free)

Dial-in international:  918-922-6528

Conference call ID:  6946137

A webcast will be available.

About MCI Onehealth Technologies Inc.

MCI Onehealth is a health care technology company focused on empowering patients and doctors with advanced technologies to increase access, improve quality and reduce health care costs. As part of the health care community for over 30 years, MCI Onehealth operates one of Canada's leading primary care networks with 25 clinics, serves more than one million patients annually and had nearly 300,000 telehealth visits last year, including on-line visits. MCI Onehealth additionally offers an expanding suite of occupational health service offerings that support a growing list of over 550 corporate customers. Led by a proven management team of doctors and experienced executives, MCI Onehealth remains focused on executing a strategy centred around acquiring technology and health services that complement the company's current road map.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.